Developing Wearable Biosensors for Real-time Monitoring and Early Detection of Disease Biomarkers

Posted on May 19, 2023  •  3 minutes  • 555 words

Scientists at ETH Zurich are developing a new generation of wearable biosensors for the real-time monitoring and early detection of disease biomarkers. These devices will have the capability to monitor biophysical and biochemical signals in real-time and alert patients and their healthcare providers of potential health issues before they become major problems.

The researchers are focusing on developing thin, flexible electronic devices that can be worn on the skin like a patch or a tattoo without causing discomfort for the patient. These wearable biosensors will be able to detect various biomarkers such as glucose, cholesterol, lactate, and other metabolites that are associated with various diseases. This technology is expected to play a key role in the early detection and management of conditions such as diabetes, heart disease, and cancer, which are major health concerns worldwide.

The team at ETH Zurich is using advanced nanomaterials and manufacturing techniques to develop these next-generation biosensors. The devices are being designed to be highly sensitive, specific, and versatile to detect a wide range of biomarkers with high accuracy and reliability. This new technology will revolutionize the way healthcare providers monitor and treat disease by providing real-time data on the patient’s health status.

According to Professor Jan van Hest, Head of the Laboratory of Organic Chemistry at ETH Zurich:

Wearable biosensors will be a game-changer for healthcare. They will provide patients with real-time feedback on their health status, allowing them to take action before a condition becomes severe.

The technology will help patients and their healthcare providers to manage chronic conditions more effectively and preempt serious health issues before they arise.

There are several advantages of the new wearable biosensors that ETH Zurich is developing. The devices are non-invasive and can be worn continuously, making them much more convenient for patients to use. They are also more accurate and reliable than traditional diagnostic tests, which often require patients to visit a healthcare facility to undergo testing. This advancement in diagnostic technology could be especially helpful in remote or underserved areas where access to healthcare facilities is limited, or during a global health crisis such as COVID-19.

The development of wearable biosensors for disease monitoring is an exciting area of research, and the team at ETH Zurich is at the forefront of this innovation. Their efforts could lead to a new era of healthcare where wearable biosensors are routinely used for the early detection and management of disease. With this new technology, patients can take a more proactive role in managing their health, and healthcare providers can monitor patients' health status more efficiently and effectively.

Wearable biosensors are going to play a critical role in healthcare in the next few years. These devices will enable patients to take an active role in their healthcare, providing them with real-time feedback on their health status and enabling early detection of diseases. The research being done at ETH Zurich is at the cutting edge of this technology. Their work will pave the way to a new era of healthcare, where wearable biosensors are routinely used to monitor and manage disease.

References

1. Next-generation digital biomarkers: continuous molecular health monitoring using wearable devices
2. Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications
3. A novel theoretical model for predicting the individuals’ thermal sensations based on air temperature and biomarkers measured by wearable devices

Share

Tags

Counters